Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors
SEATTLE, March 31, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointment
Source: kulr8.com